Debiopharm

Debiopharm is a leading pharmaceutical company dedicated to bridging the gap between innovative discovery products and ensuring they reach patients worldwide. By focusing on the in-licensing of high-potential compounds, Debiopharm excels in clinical development. The company strategically partners with large pharmaceutical entities for out-licensing, maximizing patient access on a global scale.

Debiopharm specializes in developing prescription drugs that address critical unmet medical needs, particularly in oncology and bacterial infections. With a proven track record, Debiopharm has successfully developed and licensed out key compounds, demonstrating its commitment to advancing healthcare solutions. The primary address for Debiopharm is Chemin Messidor 5-7, Lausanne, 1006, CH, with an additional location at Rue du Levant 146, Martigny, 1920, CH.

Debiopharm continues to drive innovation and excellence in the pharmaceutical industry. The company’s model ensures that promising early-stage research molecules are developed to their full potential. Debiopharm is always open to collaboration and welcomes inquiries from universities and biotech start-ups with groundbreaking molecules. We invite the manager of Debiopharm to create a customized and exclusive company showcase and product listing on our platform, enhancing your visibility and commercial opportunities.